Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 20;22(1):52.
doi: 10.1186/s12874-022-01536-6.

Assessing transferability in systematic reviews of health economic evaluations - a review of methodological guidance

Affiliations
Review

Assessing transferability in systematic reviews of health economic evaluations - a review of methodological guidance

Alina Weise et al. BMC Med Res Methodol. .

Abstract

Objective: For assessing cost-effectiveness, Health Technology Assessment (HTA) organisations may use primary economic evaluations (P-HEs) or Systematic Reviews of Health Economic evaluations (SR-HEs). A prerequisite for meaningful results of SR-HEs is that the results from existing P-HEs are transferable to the decision context (e.g, HTA jurisdiction). A particularly pertinent issue is the high variability of costs and resource needs across jurisdictions. Our objective was to review the methods documents of HTA organisations and compare their recommendations on considering transferability in SR-HE.

Methods: We systematically hand searched the webpages of 158 HTA organisations for relevant methods documents from 8th January to 31st March 2019. Two independent reviewers performed searches and selected documents according to pre-defined criteria. One reviewer extracted data in standardised and piloted tables and a second reviewer checked them for accuracy. We synthesised data using tabulations and in a narrative way.

Results: We identified 155 potentially relevant documents from 63 HTA organisations. Of these, 7 were included in the synthesis. The included organisations have different aims when preparing a SR-HE (e.g. to determine the need for conducting their own P-HE). The recommendations vary regarding the underlying terminology (e.g. transferability/generalisability), the assessment approaches (e.g. structure), the assessment criteria and the integration in the review process.

Conclusion: Only few HTA organisations address the assessment of transferability in their methodological recommendations for SR-HEs. Transferability considerations are related to different purposes. The assessment concepts and criteria are heterogeneous. Developing standards to consider transferability in SR-HEs is desirable.

Keywords: Applicability; External validity; Generalisability; Health economic evaluations; Health technology assessment; Methods; Transferability.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA Flow-Chart of document selection

References

    1. Garattini L, Casadei G. Health technology assessment: for whom the bell tolls? Eur J Health Econ. 2008;9(4):311–312. doi: 10.1007/s10198-008-0113-6. - DOI - PubMed
    1. Anderson R. Systematic reviews of economic evaluations: utility or futility? Health Econ. 2010;19(3):350–364. doi: 10.1002/hec.1486. - DOI - PubMed
    1. Goeree R, He J, O'Reilly D, Tarride JE, Xie F, Lim M, et al. Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. Clinicoecon Outcomes Res. 2011;3:89–104. doi: 10.2147/CEOR.S14404. - DOI - PMC - PubMed
    1. Burford B, Lewin S, Welch V, Rehfuess E, Waters E. Assessing the applicability of findings in systematic reviews of complex interventions can enhance the utility of reviews for decision making. J Clin Epidemiol. 2013;66(11):1251–1261. doi: 10.1016/j.jclinepi.2013.06.017. - DOI - PubMed
    1. Jacobsen E, Boyers D, Avenell A. Challenges of systematic reviews of economic evaluations: a review of recent reviews and an obesity case study. Pharmacoeconomics. 2020;38(3):259–267. doi: 10.1007/s40273-019-00878-2. - DOI - PMC - PubMed